158 related articles for article (PubMed ID: 37977244)
1. Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH.
Boesch M; Lindhorst A; Feio-Azevedo R; Brescia P; Silvestri A; Lannoo M; Deleus E; Jaekers J; Topal H; Topal B; Ostyn T; Wallays M; Smets L; Van Melkebeke L; Härtlova A; Roskams T; Bedossa P; Verbeek J; Govaere O; Francque S; Sifrim A; Voet T; Rescigno M; Gericke M; Korf H; van der Merwe S
J Hepatol; 2024 Mar; 80(3):397-408. PubMed ID: 37977244
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease.
Martínez-Sánchez C; Bassegoda O; Deng H; Almodóvar X; Ibarzabal A; de Hollanda A; Martínez García de la Torre RA; Blaya D; Ariño S; Jiménez-Esquivel N; Aguilar-Bravo B; Vallverdú J; Montironi C; Osorio-Conles O; Fundora Y; Sánchez Moreno FJ; Gómez-Valadés AG; Aguilar-Corominas L; Soria A; Pose E; Juanola A; Cervera M; Perez M; Hernández-Gea V; Affò S; Swanson KS; Ferrer-Fàbrega J; Balibrea JM; Sancho-Bru P; Vidal J; Ginès P; Smith AM; Graupera I; Coll M
JHEP Rep; 2023 Oct; 5(10):100830. PubMed ID: 37701336
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
5. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
[TBL] [Abstract][Full Text] [Related]
6. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
[TBL] [Abstract][Full Text] [Related]
7. Macrophage functional diversity in NAFLD - more than inflammation.
Barreby E; Chen P; Aouadi M
Nat Rev Endocrinol; 2022 Aug; 18(8):461-472. PubMed ID: 35534573
[TBL] [Abstract][Full Text] [Related]
8. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice.
Bijnen M; Josefs T; Cuijpers I; Maalsen CJ; van de Gaar J; Vroomen M; Wijnands E; Rensen SS; Greve JWM; Hofker MH; Biessen EAL; Stehouwer CDA; Schalkwijk CG; Wouters K
Gut; 2018 Jul; 67(7):1317-1327. PubMed ID: 29074725
[TBL] [Abstract][Full Text] [Related]
10. Macrophages and the development and progression of non-alcoholic fatty liver disease.
Alabdulaali B; Al-Rashed F; Al-Onaizi M; Kandari A; Razafiarison J; Tonui D; Williams MR; Blériot C; Ahmad R; Alzaid F
Front Immunol; 2023; 14():1195699. PubMed ID: 37377968
[TBL] [Abstract][Full Text] [Related]
11. Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.
Thibaut R; Gage MC; Pineda-Torra I; Chabrier G; Venteclef N; Alzaid F
FEBS J; 2022 Jun; 289(11):3024-3057. PubMed ID: 33860630
[TBL] [Abstract][Full Text] [Related]
12. [Macrophage heterogeneity role in NAFLD and NASH disease progression].
Yang T; Wang X; Jiang LF; Li J
Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):770-775. PubMed ID: 37580264
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.
Saponaro C; Sabatini S; Gaggini M; Carli F; Rosso C; Positano V; Armandi A; Caviglia GP; Faletti R; Bugianesi E; Gastaldelli A
Liver Int; 2022 Nov; 42(11):2418-2427. PubMed ID: 35900229
[TBL] [Abstract][Full Text] [Related]
14. Macrophage Subsets in Obesity, Aligning the Liver and Adipose Tissue.
Remmerie A; Martens L; Scott CL
Front Endocrinol (Lausanne); 2020; 11():259. PubMed ID: 32411096
[TBL] [Abstract][Full Text] [Related]
15. Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis.
Krenkel O; Hundertmark J; Abdallah AT; Kohlhepp M; Puengel T; Roth T; Branco DPP; Mossanen JC; Luedde T; Trautwein C; Costa IG; Tacke F
Gut; 2020 Mar; 69(3):551-563. PubMed ID: 31076404
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
[TBL] [Abstract][Full Text] [Related]
17. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications.
Alisi A; Carpino G; Oliveira FL; Panera N; Nobili V; Gaudio E
Mediators Inflamm; 2017; 2017():8162421. PubMed ID: 28115795
[TBL] [Abstract][Full Text] [Related]
18. Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages.
He W; Huang Y; Shi X; Wang Q; Wu M; Li H; Liu Q; Zhang X; Huang C; Li X
J Transl Med; 2023 Jul; 21(1):448. PubMed ID: 37415134
[TBL] [Abstract][Full Text] [Related]
19. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.
Govaere O; Petersen SK; Martinez-Lopez N; Wouters J; Van Haele M; Mancina RM; Jamialahmadi O; Bilkei-Gorzo O; Lassen PB; Darlay R; Peltier J; Palmer JM; Younes R; Tiniakos D; Aithal GP; Allison M; Vacca M; Göransson M; Berlinguer-Palmini R; Clark JE; Drinnan MJ; Yki-Järvinen H; Dufour JF; Ekstedt M; Francque S; Petta S; Bugianesi E; Schattenberg JM; Day CP; Cordell HJ; Topal B; Clément K; Romeo S; Ratziu V; Roskams T; Daly AK; Anstee QM; Trost M; Härtlova A
J Hepatol; 2022 May; 76(5):1001-1012. PubMed ID: 34942286
[TBL] [Abstract][Full Text] [Related]
20. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
